Press Releases on November 3, 2022 - EIN Presswire - Press Release Distribution Service

Published on November 3, 2022 - 20:01 GMT

Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results

Initiated Phase 3 global registrational Study ZILO-301 of our zilovertamab product candidate targeting ROR1 in combination with ibrutinib for the treatment of patients with MCL Received acceptance for an oral presentation at the 64th ASH Annual Meeting and …

Distribution channels: Business & Economy, Technology ...

Published on November 3, 2022 - 20:01 GMT

Research Frontiers Reports Third Quarter 2022 Financial Results and Will Host a Conference Call at 4:30p.m. Today

WOODBURY, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its September 30, 2022 third quarter. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its …

Distribution channels: Electronics Industry ...

Published on November 3, 2022 - 20:01 GMT

Ventyx Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress

We are on track to initiate Phase 2 trials of our allosteric TYK2 inhibitor VTX958 in psoriasis, Crohn’s disease and psoriatic arthritis this quarter Cash, cash equivalents and marketable securities of $412.4 million as of September 30, 2022, including …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

S Split Corp. Declares Monthly Distribution

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- (TSX: SBN; SBN.PR.A) S Split Corp. has declared a monthly distribution, payable on November 30, 2022 to shareholders of record on November 15, 2022. Due to the decline in the net asset value (“NAV”) per unit below …

Distribution channels: Banking, Finance & Investment Industry

Published on November 3, 2022 - 20:01 GMT

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution For its ETF Class

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly fund distribution for its ETF Class in the amount of $0.04667 per unit, payable on December 7, 2022 to unitholders of record on November 30, 2022. For …

Distribution channels: Banking, Finance & Investment Industry

Published on November 3, 2022 - 20:01 GMT

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly fund distribution in the amount of $0.058333 per unit, payable on December 7, 2022 to unitholders of record on November 30, 2022. For …

Distribution channels: Banking, Finance & Investment Industry

Published on November 3, 2022 - 20:01 GMT

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

Freeline Reports October 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LONDON, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on October 31, 2022, the Company granted three newly hired employees non-statutory options to purchase an aggregate of 75,500 of the Company’s …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on November 3, 2022 - 20:01 GMT

MacroGenics Provides Corporate Update and Third Quarter 2022 Financial Results

Collaboration with Gilead to develop bispecific antibodies, including MGD024, announced Planned initiation of Phase 2 portion of MGC018 TAMARACK study in prostate cancer by year-end Anticipated update on lorigerlimab (PD-1 × CTLA-4 bispecific DART® …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

NV5 Announces Record Third Quarter Results; Exceeds Analyst Consensus

HOLLYWOOD, Fla., Nov. 03, 2022 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (Nasdaq: NVEE) ("NV5" or the "Company"), a provider of technology, conformity assessment, and consulting solutions, today reported financial results for the third …

Distribution channels: Business & Economy, Technology ...

Published on November 3, 2022 - 20:01 GMT

Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress

FT596+R Enrollment Ongoing in Three-dose Escalation Cohort for R/R BCL; Activating Community Sites for Investigation of FT596+R-CHOP in Newly-diagnosed Patients with Aggressive BCL Positive Feedback Received from FDA under FT516 RMAT Designation for …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

Miromatrix to Report Third Quarter 2022 Financial Results

EDEN PRAIRIE, Minn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress

Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled BA3011 Undifferentiated Pleomorphic Sarcoma (UPS) enrollment in Phase 2 part 2 of study anticipated to begin by year- …

Distribution channels: Business & Economy, Technology ...

Published on November 3, 2022 - 20:01 GMT

Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress

– Patient enrollment continuing in Phase 1 clinical trial of exoASO™-STAT6 in patients with advanced hepatocellular carcinoma; preliminary data anticipated during 1H 2023 – – Presented preclinical data showing exoVACC™ pan beta coronavirus vaccine, …

Distribution channels: Business & Economy, Technology ...

Published on November 3, 2022 - 20:01 GMT

Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business Progress

– 55% year-over-year revenue growth in Q3 2022 – On track to achieve all 2022 ELEVATE! milestones – Strong balance sheet with $180.2 million in cash, cash equivalents, and available-for-sale securities at the end of Q3 2022 – Conference call today, …

Distribution channels: Business & Economy ...

Published on November 3, 2022 - 20:01 GMT

Apellis Announces Plans to Submit 24-Month Phase 3 Data to the FDA for Pegcetacoplan NDA for Geographic Atrophy (GA)

Inclusion of the 24-month data has the potential to strengthen the product profile at launch, with minimal impact to launch timing Submission will be a Major Amendment to the New Drug Application (NDA), extending the review period by three months with an …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 3, 2022 - 20:01 GMT

TPI Composites, Inc. Announces Third Quarter 2022 Earnings Results – Announces Long-term Global Partnership with Vestas, Supply ...

SCOTTSDALE, Ariz., Nov. 03, 2022 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (Nasdaq: TPIC), today reported financial results for the third quarter ended September 30, 2022. “In the third quarter, TPI delivered strong adjusted EBITDA growth and finished the …

Distribution channels: Business & Economy, Companies ...

Published on November 3, 2022 - 20:01 GMT

Capricor Therapeutics to Present Third Quarter 2022 Financial Results and Recent Corporate Update on November 10

SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 3, 2022 - 20:01 GMT

Kratos Reports Third Quarter 2022 Financial Results

SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, today reported its third quarter 2022 financial results. For the third quarter of 2022, Kratos …

Distribution channels: Aviation & Aerospace Industry, Business & Economy ...

Published on November 3, 2022 - 20:01 GMT

MercadoLibre, Inc. Third Quarter 2022 Letter to Shareholders

Net Revenues of $2.7 billion, up 60.6% year-over-year on an FX neutral basis Income from operations of $296 million, with a 11.0% margin $32.2 billion Total Payment Volume, up 76.4% year-over-year on an FX neutral basis $8.6 billion Gross Merchandise …

Distribution channels: Business & Economy, Retail ...